Oral terbutaline after parenteral tocolysis.
Lagace
E
E
lagac001@gold.tc.umn.edu
D000284:Administration, Oral; D036861:Delivery, Obstetric; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy* / Q000517:prevention & control; D011247:Pregnancy / Q000187:drug effects*; D011256:Pregnancy Outcome; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D013726:Terbutaline / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D015145:Tocolysis / Q000379:methods*; D015149:Tocolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*
D015149:Tocolytic Agents; D013726:Terbutaline